Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/13
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOjo, G.O.-
dc.date.accessioned2018-08-31T10:38:27Z-
dc.date.available2018-08-31T10:38:27Z-
dc.date.issued1968-06-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/13-
dc.descriptionA THESIS IN THE DEPARTMENT OF PHYSIOLOGY SUBMITTED TO THE FACULTY OF MEDICINE IN PARTIAL FULFILLMENT OF THE THE REQUIREMENTS OF THE DEGREE DOCTOR OF PHILOSOPHY OF THE UNIVERSITY OF IBADAN, IBADAN, NIGERIA.en_US
dc.description.abstractENDONYOCARDIAL FIBROSIS (E.M.F) is a common heart disease in certain areas of Africa. Much knowledge has accumulated in recent years about the pathology and clinical features of this disease; but at present, its pathogenesis is still in the realms of conjecture. 5-hydroxytroptamine has been implicated in the pathogenesis of E.M.F. on the basis of the role of this substance in causing cardiac lessions in the carcinoid syndrome. it is believed that E.M.F. and carcinoid heart disease have many features in common. Thus high serum level of 5-HT, as in carcinoid heart disease, is postulated to occur in E.M.F. and cause cardiac damage in this condition.en_US
dc.language.isoenen_US
dc.subject5-HYDROXYTRYPTAMINEen_US
dc.subjectPATHOGENESISen_US
dc.subjectENDONYOCARDIAL FIBROSISen_US
dc.titleTHE ROLE OF 5-HYDROXYTRYPTAMINE IN THE PATHOGENESIS OF ENDONYOCARDIAL FIBROSISen_US
dc.typeThesisen_US
Appears in Collections:Theses in Physiology

Files in This Item:
File Description SizeFormat 
OJO.pdffull text10.57 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.